HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch

STAT+: Sanofi research priorities in flux as new CEO logs in

A gene therapy for deafness, all eyes on Erasca, and other biotech news from The Readout

By STAT News · Apr 23, 2026 · via STAT News
STAT+: Sanofi research priorities in flux as new CEO logs in

Image: STAT News

Tags
peopleformat:headlineheadlineSTAT News
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from People
All People →
Who is Dr. Houman Hemmati, potentially CBER’s next leader?
PeoplePharmaVoice ↗
Where the rumored frontrunner stands on key issues like vaccines and public health policy.…
Apr 20, 2026
Teva launches new online schizophrenia community project
PeopleFiercePharma ↗
Just two months after the FDA accepted for review Teva’s long-acting version of a decades-old schizophrenia dr…
Apr 18, 2026
Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
PeopleFiercePharma ↗
Omnicom Health has stamped its mark on the recently acquired FCB Health New York, rebranding the ad agency as …
Apr 18, 2026